Point72 Asia (Singapore) Pte. Ltd. Xencor Inc Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $532 Billion
- Q3 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Xencor Inc stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 12,156 shares of XNCR stock, worth $222,211. This represents 0.05% of its overall portfolio holdings.
Number of Shares
12,156
Previous 11,207
8.47%
Holding current value
$222,211
Previous $212 Million
15.23%
% of portfolio
0.05%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding XNCR
# of Institutions
214Shares Held
71.8MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$203 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$167 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.6MShares$139 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$97.4 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$71.8 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.09B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...